LifeMD, Inc.LFMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.23% | +48.83% | +22.81% | +12.95% | -90.71% |
| Gross Profit Growth | +38.78% | +44.28% | +20.05% | +9.34% | -117.96% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | -305.99% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | -820.52% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +14.97% | +9.92% | +7.52% | +9.86% | +10.82% |
| Weighted Average Shares Diluted Growth | +14.97% | +16.15% | +7.52% | +9.86% | +10.82% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -72.55% | -41.02% | +90.31% | -102.37% | -309.17% |
| Free Cash Flow Growth | -132.95% | -93.32% | +717.40% | +136.93% | +0.00% |
| Receivables Growth | +55.72% | +91.00% | +29.33% | +52.81% | +13.23% |
| Inventory Growth | +1.36% | +25.03% | +57.78% | +29.75% | -0.85% |
| Asset Growth | +23.90% | +19.79% | +15.27% | -9.06% | -2.83% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +32.59% | +26.10% | +4.26% | -74.05% | -74.81% |
| R&D Expense Growth | +20.65% | +28.17% | +14.22% | +8.98% | -100.00% |
| SG&A Expenses Growth | +27.26% | +17.15% | +3.99% | +2.99% | -24.34% |